Drugs / ACCU-D1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03064438 | Nov 2017 → Jun 2018 | rosacea | Accuitis, Inc. | Completed | Missed primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ACCU-D1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03064438 ↗ |